Artwork

内容由RealPharma提供。所有播客内容(包括剧集、图形和播客描述)均由 RealPharma 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Decoding HEOR: Iris Tam's Insights on Pharma's Value-Based Future

49:26
 
分享
 

Manage episode 408912178 series 3535889
内容由RealPharma提供。所有播客内容(包括剧集、图形和播客描述)均由 RealPharma 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Join us on a deep dive into the world of Health Economics and Outcomes Research (HEOR) with the remarkable Iris Tam, PharmD, a luminary in value-based evidence generation within the biopharma industry. In this episode, our hosts Ian and Na-Ri explore with Iris the critical role of HEOR in transforming today's pharmaceutical landscape, from drug development to global marketing strategies and beyond.

Unpacking the complexities of HEOR, they delve into its definition, significance, and the evolving importance of this field in aligning drug development with payer expectations and patient outcomes. Iris shares invaluable insights on the key elements that payers scrutinize in HEOR studies, and the strategic considerations essential for successful global product launches.

Ethical considerations in HEOR research also take center stage, highlighting the responsibility of ensuring integrity and patient-centricity in evidence generation. For professionals eager to make their mark in HEOR or advance their careers, Iris offers sage advice, emphasizing the need for robust data, the value of learning from post-mortems, and the art of using failures to forge successful future strategies.

This episode is not just an exploration of HEOR's impact on healthcare but a guide to understanding the challenges of demonstrating product value and the crucial role of user adoption. Whether you're a seasoned professional or new to the field, Iris's journey and insights offer inspiration and guidance for navigating the complexities of HEOR in the biopharma industry.

Chapters

  • 00:00 Introduction of Iris Tam

  • 02:08 Definition and Significance of HEOR

  • 04:07 Evolution and Increasing Role of HEOR

  • 07:49 Components of HEOR: Health Economics and Outcomes Research

  • 10:26 Impact of HEOR on Drug Development and Marketing Strategies

  • 25:46 Key Elements for Payers in HUR Studies

  • 38:47 Considerations for HUR in Global Launches

  • 41:35 Ethical Considerations in HUR Research

  • 46:41 Skills and Experiences for Success in HUR

  • 51:49 The importance of user adoption

  • 52:01 Learning from post mortems

  • 53:01 Using failures to inform future strategies

  • 53:55 The challenge of proving product benefits

  • 54:23 Closing thoughts and advice

Resources:

  continue reading

15集单集

Artwork
icon分享
 
Manage episode 408912178 series 3535889
内容由RealPharma提供。所有播客内容(包括剧集、图形和播客描述)均由 RealPharma 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Join us on a deep dive into the world of Health Economics and Outcomes Research (HEOR) with the remarkable Iris Tam, PharmD, a luminary in value-based evidence generation within the biopharma industry. In this episode, our hosts Ian and Na-Ri explore with Iris the critical role of HEOR in transforming today's pharmaceutical landscape, from drug development to global marketing strategies and beyond.

Unpacking the complexities of HEOR, they delve into its definition, significance, and the evolving importance of this field in aligning drug development with payer expectations and patient outcomes. Iris shares invaluable insights on the key elements that payers scrutinize in HEOR studies, and the strategic considerations essential for successful global product launches.

Ethical considerations in HEOR research also take center stage, highlighting the responsibility of ensuring integrity and patient-centricity in evidence generation. For professionals eager to make their mark in HEOR or advance their careers, Iris offers sage advice, emphasizing the need for robust data, the value of learning from post-mortems, and the art of using failures to forge successful future strategies.

This episode is not just an exploration of HEOR's impact on healthcare but a guide to understanding the challenges of demonstrating product value and the crucial role of user adoption. Whether you're a seasoned professional or new to the field, Iris's journey and insights offer inspiration and guidance for navigating the complexities of HEOR in the biopharma industry.

Chapters

  • 00:00 Introduction of Iris Tam

  • 02:08 Definition and Significance of HEOR

  • 04:07 Evolution and Increasing Role of HEOR

  • 07:49 Components of HEOR: Health Economics and Outcomes Research

  • 10:26 Impact of HEOR on Drug Development and Marketing Strategies

  • 25:46 Key Elements for Payers in HUR Studies

  • 38:47 Considerations for HUR in Global Launches

  • 41:35 Ethical Considerations in HUR Research

  • 46:41 Skills and Experiences for Success in HUR

  • 51:49 The importance of user adoption

  • 52:01 Learning from post mortems

  • 53:01 Using failures to inform future strategies

  • 53:55 The challenge of proving product benefits

  • 54:23 Closing thoughts and advice

Resources:

  continue reading

15集单集

Όλα τα επεισόδια

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南